Acute pancreatitis in patients with type 2 diabetes mellitus treated with dipeptidyl peptidase-4 inhibitors

Dipeptidyl peptidase (DPP)-4 inhibitors are approved for use in monotherapy or in combination therapy for patients with type 2 diabetes mellitus for <1 decade. However, numerous reports of DPP-4 inhibitors induced acute pancreatitis were made through the US Food and Drug Administration Adverse Ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Tzu-Lin, Shen, Mei-Chiou, Yu, Ming-Lung, Huang, Yaw-Bin, Chen, Chung-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taiwan Food and Drug Administration 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339562/
https://www.ncbi.nlm.nih.gov/pubmed/28911601
http://dx.doi.org/10.1016/j.jfda.2016.01.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339562/
https://www.ncbi.nlm.nih.gov/pubmed/28911601
http://dx.doi.org/10.1016/j.jfda.2016.01.009

Ejemplares similares